Feed Preview

Fast Growing

Frontotemporal Dementia

Frontotemporal Dementia diagram by Atthapon Raksthaput, Shutterstock
Atthapon Raksthaput, Shutterstock

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

Top 20 most recent papers
Annals of Oncology : Official Journal of the European Society for Medical Oncology

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

Annals of Oncology : Official Journal of the European Society for Medical OncologyJanuary 9, 2020
T YoshinoH-J Lenz
3
Neurology

ALS phenotype is influenced by age, sex, and genetics: A population-based study

NeurologyJanuary 8, 2020
Adriano ChiòAndrea Calvo
12
1
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Howard J RosenAdam L Boxer
2
1
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Toji MiyagawaZbigniew Wszolek
1
1
Brain : a Journal of Neurology

Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy

Brain : a Journal of NeurologyJanuary 17, 2020
Merilee TeylanJohn F Crary
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Eliana Marisa RamosGiovanni Coppola
1
1
The EMBO Journal

Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders

The EMBO JournalJanuary 14, 2020
Manon BoivinNicolas Charlet-Berguerand
3
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Hilary W HeuerARTFL and LEFFTDS consortia
4
1
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Kaitlin B CasalettoARTFL/LEFFTDS Study
10
5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchJanuary 12, 2020
Anna M VargheseLeonard B Saltz
4
Trends in Genetics : TIG

Omics in Neurodegenerative Disease: Hope or Hype?

Trends in Genetics : TIGJanuary 15, 2020
Maria E Diaz-Ortiz, Alice S Chen-Plotkin
22
Neurobiology of Aging

Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study

Neurobiology of AgingJanuary 11, 2020
Qin ChenKejal Kantarci
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationJanuary 9, 2020
Adam M StaffaroniARTFL/LEFFTDS consortium
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry

Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric PsychiatryJanuary 14, 2020
B OrsoM Pardini
1
Movement Disorders : Official Journal of the Movement Disorder Society

CLU rs11136000 promotes early cognitive decline in Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder SocietyJanuary 14, 2020
Frederic SampedroJaime Kulisevsky
5
The Journal of Chemical Physics

Orbital localization error of density functional theory in shear properties of vanadium and niobium

The Journal of Chemical PhysicsJanuary 17, 2020
Yi X WangXiang R Chen
PloS One

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

PloS OneJanuary 16, 2020
Hanneke F M Rhodius-MeesterWiesje M van der Flier
1
Bioorganic & Medicinal Chemistry Letters

Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia

Bioorganic & Medicinal Chemistry LettersJanuary 14, 2020
Dean G BrownHeike J Wobst
24
Acta Neuropathologica

Picalm reduction exacerbates tau pathology in a murine tauopathy model

Acta NeuropathologicaJanuary 12, 2020
Kunie AndoJean-Pierre Brion
8
Annals of Neurology

Classification accuracy of TMS for the diagnosis of neurodegenerative dementias

Annals of NeurologyJanuary 12, 2020
Alberto BenussiBarbara Borroni
21

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/frontotemporal-dementia/806b2e01-8987-48ff-a599-f71effb4d394